BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8168998)

  • 1. Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium.
    Möller P; Koretz K; Leithäuser F; Brüderlein S; Henne C; Quentmeier A; Krammer PH
    Int J Cancer; 1994 May; 57(3):371-7. PubMed ID: 8168998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas.
    Koretz K; Brüderlein S; Henne C; Möller P
    Br J Cancer; 1992 Nov; 66(5):810-4. PubMed ID: 1384641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.
    Leithäuser F; Dhein J; Mechtersheimer G; Koretz K; Brüderlein S; Henne C; Schmidt A; Debatin KM; Krammer PH; Möller P
    Lab Invest; 1993 Oct; 69(4):415-29. PubMed ID: 7693996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium.
    Koretz K; Brüderlein S; Henne C; Möller P
    Br J Cancer; 1993 Nov; 68(5):926-31. PubMed ID: 7692919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis.
    von Reyher U; Sträter J; Kittstein W; Gschwendt M; Krammer PH; Möller P
    Cancer Res; 1998 Feb; 58(3):526-34. PubMed ID: 9458101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
    Munker R; Andreeff M
    Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of VLA-alpha 2, VLA-alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastases.
    Koretz K; Schlag P; Boumsell L; Möller P
    Am J Pathol; 1991 Mar; 138(3):741-50. PubMed ID: 2000944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign to malign tumour transformation.
    Stallmach A; von Lampe B; Matthes H; Bornhöft G; Riecken EO
    Gut; 1992 Mar; 33(3):342-6. PubMed ID: 1568652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
    Weller M; Frei K; Groscurth P; Krammer PH; Yonekawa Y; Fontana A
    J Clin Invest; 1994 Sep; 94(3):954-64. PubMed ID: 7521890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa.
    Bhargava R; Chen B; Klimstra DS; Saltz LB; Hedvat C; Tang LH; Gerald W; Teruya-Feldstein J; Paty PB; Qin J; Shia J
    Cancer; 2006 Apr; 106(8):1857-62. PubMed ID: 16532444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas.
    Koornstra JJ; Kleibeuker JH; van Geelen CM; Rijcken FE; Hollema H; de Vries EG; de Jong S
    J Pathol; 2003 Jul; 200(3):327-35. PubMed ID: 12845629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-surface levels of human carcinoembryonic antigen are inversely correlated with colonocyte differentiation in colon carcinogenesis.
    Ilantzis C; Jothy S; Alpert LC; Draber P; Stanners CP
    Lab Invest; 1997 May; 76(5):703-16. PubMed ID: 9166289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered content and distribution of tenascin in colitis, colon adenoma, and colorectal carcinoma.
    Riedl SE; Faissner A; Schlag P; Von Herbay A; Koretz K; Möller P
    Gastroenterology; 1992 Aug; 103(2):400-6. PubMed ID: 1378802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface expression of tumor-associated antigens in primary cultured human colonic epithelial cells from carcinomas, benign tumors, and normal tissues.
    Friedman E; Thor A; Hand PH; Schlom J
    Cancer Res; 1985 Nov; 45(11 Pt 2):5648-55. PubMed ID: 2413994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns and composition of basement membranes in colon adenomas and adenocarcinomas.
    Visser R; Arends JW; Leigh IM; Bosman FT
    J Pathol; 1993 Jul; 170(3):285-90. PubMed ID: 8133402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the secretory component as a prognostic variable in colorectal carcinoma.
    Koretz K; Schlag P; Quentmeier A; Möller P
    Int J Cancer; 1994 May; 57(3):365-70. PubMed ID: 8168997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
    Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
    Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.